Licensee will. (a) be responsible for all reporting under this Schedule to the relevant regulatory authority in the Territory including reporting, where applicable, of any international case reports forwarded by Cellegy; (b) send to Cellegy a copy of all mail exchanges with the relevant regulatory authority in the Territory; and (c) give Cellegy timely notice of any meetings or discussions with the relevant regulatory authority in the Territory concerning the safety of any of the Licensed Products.
Appears in 2 contracts
Sources: Exclusive License Agreement (Pdi Inc), Exclusive License Agreement (Cellegy Pharmaceuticals Inc)